Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teicoplanin pharmacokinetics/pharmacodynamics in sepsis with hypoproteinemia
ChiCTR1900021160Phase 4Recruiting
- Sponsor
- Affiliated Hospital of Putian University
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of teicoplanin in sepsis and Gram-positive bacterial infection, sponsored by Affiliated Hospital of Putian University. Primary endpoints: Trough concentration, Albumin and 1 more. Started Mar 2019; status: recruiting.
02
Drugs
teicoplanin
03
Conditions
sepsisGram-positive bacterial infection
Beyond the preview
Go deeper on ChiCTR1900021160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021160.